Atea Pharmaceuticals, Inc. (AVIR) NASDAQ
4.24
+0.05(+1.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.24
+0.05(+1.19%)
Currency In USD
| Market Cap | 290.94M |
| Enterprise Value | 196.07M |
| P/E Ratio | -1.98 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.44 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.57 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -180.47M |
| Net Income | -158.35M |
| Diluted EPS | -1.94 |
| Total Cash | 256.01M |
| Total Cash/Share | 3.23 |
| Total Debt | 634,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.89 |
| Book Value Per Share | 2.95 |
| 52-Week Change | 50.89 |
| 52-Week High | 6.45 |
| 52-Week Low | 2.78 |
| Moving Average 50 Days | 5.49 |
| Moving Average 200 Days | 4.02 |
| Average Volume | 446,603 |
| Shares Outstanding | 80.03M |
| % Held by Institutions | 19.68 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |